Effects of TSP-1-696 C/T polymorphism on bladder cancer susceptibility and clinicopathologic features.

MLA

Gu, Jinbao, et al. “Effects of TSP-1-696 C/T Polymorphism on Bladder Cancer Susceptibility and Clinicopathologic Features.” Cancer Genetics, vol. 207, no. 6, June 2014, pp. 247–52. EBSCOhost, https://doi.org/10.1016/j.cancergen.2014.06.023.

APA

Gu, J., Tao, J., Yang, X., Li, P., Yang, X., Qin, C., Cao, Q., Cai, H., Zhang, Z., Wang, M., Gu, M., Lu, Q., & Yin, C. (2014). Effects of TSP-1-696 C/T polymorphism on bladder cancer susceptibility and clinicopathologic features. Cancer Genetics, 207(6), 247–252. https://doi.org/10.1016/j.cancergen.2014.06.023

Chicago

Gu, Jinbao, Jun Tao, Xiao Yang, Pengchao Li, Xuejian Yang, Chao Qin, Qiang Cao, et al. 2014. “Effects of TSP-1-696 C/T Polymorphism on Bladder Cancer Susceptibility and Clinicopathologic Features.” Cancer Genetics 207 (6): 247–52. doi:10.1016/j.cancergen.2014.06.023.